Gabrielle Pierre-Henry

French eye doctor, Vitreo-retinal consultant @ Dijon University Hospital, Researcher @ (CSGA INRA Dijon, France) & Save Sight Institute (Sydney, Australia).

[François Rebsamen @frebsamen]

Fier de la présence persistante de l'uB dans le prestigieux classement de Shanghai malgré la compétitivité toujours + intense des universités anglo-saxonnes.

Félicitations au Président THOMAS et aux équipes des labo. de recherche pour leur travail scientifique remarquable !

[Gabrielle Pierre-Henry @phgabriellemd]

@meelonmuskusa 56

[Ophthalmology @AAOjournal]

Analysis found patients receiving anti-VEGF inhibitors for diabetic macular edema at >2/3rd of their visits, a measure of treatment intensity, generally had better 1yr visual acuity and anatomic outcomes. @phgabriellemd @SydneySaveSight @FRB_Research https://t.co/RXGm5MnM8m

[Javier Zarranz-Ventura @JavierZarranz]

Excellent piece of work led by @phgabriellemd @CHUDijon! Glad to participate from @hospitalclinic @idibaps in another meaningful @AAOjournal paper from the global @FRB_Research team 🌍👁️💪 Keep up the hard work!!! @SydneySaveSight @Sydney_Uni #RealWorldData #IntravitrealTherapy

[Ophthalmology @AAOjournal]

Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! Registry
https://t.co/MPOH2afwSI
@phgabriellemd @CHUDijon @FRB_Research @SydneySaveSight @Sydney_Uni

[Fight Retinal Blindness! (FRB!) @FRB_Research]

SSR has upgraded its macular degeneration module to capture data for both wet and dry macular degeneration. We are discussing this exciting development with Users in an upcoming webinar. Visit our website for more details. https://t.co/iLo0QrPfzH

[Gabrielle Pierre-Henry @phgabriellemd]

The article is available in #openaccess

A huge thank you to my mentors Catherine Creuzot-Garcher and Mark Gillies and my co-authors Daniel Barthelmes, Hemal Mehta, @Vincedaien , and Vuong Nguyen.
@CHUDijon @Univ_BFC @univbourgogne

[Gabrielle Pierre-Henry @phgabriellemd]

From randomised controlled trials to real-world data: Clinical evidenc... https://t.co/QINyQDGE5U

[Gabrielle Pierre-Henry @phgabriellemd]

Why read it? To stay updated with the comprehensive knowledge on #DME. RCT and Real-world evidence #RWE are combined to provide evidence-based guidelines to manage #DME.

[Fight Retinal Blindness! (FRB!) @FRB_Research]

Our colleagues in France have led an analysis on the effect of HbA1c level and glomerular filtration rate on treatment outcomes in patients with #DME receiving anti-VEGF injections. The study used data from the Fight Retinal Blindness! registry. Read more below.👀

[JAMA Ophthalmology @JAMAOphth]

Study highlights hallucinated citations when using an AI chatbot to recommend ophthalmic sources and create scientific abstracts. https://t.co/H1HJ2zbEtl

[JAMA Ophthalmology @JAMAOphth]

In this randomized trial of low-dose 0.01% atropine eyedrops vs placebo, 0.01% atropine eyedrops did not slow myopia progression or axial elongation over two years, which does not support its use in US children. Stronger concentrations should be studied. https://t.co/P5EJgUEG3H

[Tim Cook @tim_cook]

https://t.co/7JIDCKC5Ux

[Ophthalmology @AAOjournal]

In a randomized controlled trial, surgical vitrectomy was not superior to pneumatic displacement in managing submacular hemorrhage secondary to age-related #maculardegeneration, with TPA and ranibizumab added to each arm. @phgabriellemd @CHUDijon https://t.co/ObIgKQUuJl

[Gabrielle Pierre-Henry @phgabriellemd]

STAR Trial: Surgery Not Superior to Pneumatic Displacement for Submacular Hemorrhage https://t.co/jb2SZgl4eH via @mdmagazine

[Gabrielle Pierre-Henry @phgabriellemd]

#Ophthalmology #retina #AMD #research #Science 😃👁️🔬🤓

[Gabrielle Pierre-Henry @phgabriellemd]

Feeling happy and proud :) not every day that you receive that kind of email from the blue journal @aao_ophth @AAOjournal Achievement of an enormous French collaborative work. More information on the findings of our RCT on the treatment of submacular hemorrhage soon @CHUDijon